Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure.

The Journal of Biological Chemistry
Jorge ParodiLuis G Aguayo

Abstract

Alzheimer disease is a progressive neurodegenerative brain disorder that leads to major debilitating cognitive deficits. It is believed that the alterations capable of causing brain circuitry dysfunctions have a slow onset and that the full blown disease may take several years to develop. Therefore, it is important to understand the early, asymptomatic, and possible reversible states of the disease with the aim of proposing preventive and disease-modifying therapeutic strategies. It is largely unknown how amyloid beta-peptide (A beta), a principal agent in Alzheimer disease, affects synapses in brain neurons. In this study, we found that similar to other pore-forming neurotoxins, A beta induced a rapid increase in intracellular calcium and miniature currents, indicating an enhancement in vesicular transmitter release. Significantly, blockade of these effects by low extracellular calcium and a peptide known to act as an inhibitor of the A beta-induced pore prevented the delayed failure, indicating that A beta blocks neurotransmission by causing vesicular depletion. This new mechanism for A beta synaptic toxicity should provide an alternative pathway to search for small molecules that can antagonize these effects of A beta.

References

May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·T A RyanH Reuter
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·A Y HsiaL Mucke
Sep 25, 2001·Cellular and Molecular Neurobiology·J I KourieP Farrelly
Sep 27, 2001·The Journal of Biological Chemistry·A C AshtonY A Ushkaryov
Jul 12, 2002·Journal of Neuroscience Research·Neelima B Chauhan, George J Siegel
Oct 26, 2002·Science·Dennis J Selkoe
Aug 12, 2003·Cell Calcium·Mark P Mattson, Sic L Chan
Mar 12, 2004·The Journal of Membrane Biology·N Arispe
Jun 9, 2004·Protein and Peptide Letters·Dominic M Walsh, Dennis J Selkoe
Dec 22, 2004·Nature Reviews. Neuroscience·Silvio O Rizzoli, William J Betz
Feb 22, 2005·The Journal of Biological Chemistry·Angelo DemuroCharles G Glabe
Apr 27, 2005·Journal of Alzheimer's Disease : JAD·P Hemachandra ReddyMaria Manczak
May 28, 2005·Current Opinion in Neurobiology·Ralf Schneggenburger, Erwin Neher
Jul 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Arjan QuistRatnesh Lal
Jul 19, 2005·Nature Neuroscience·Eric M SnyderPaul Greengard
Jul 26, 2006·The Journal of Biological Chemistry·Brent L Kelly, Adriana Ferreira
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Mar 16, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ganesh M ShankarBernardo L Sabatini
May 11, 2007·Biochimica Et Biophysica Acta·Nelson ArispeOlga Simakova

❮ Previous
Next ❯

Citations

Jun 21, 2013·Acta Neuropathologica·Iñaki-Carril MundiñanoMaria-Rosario Luquin
Oct 30, 2012·Molecules and Cells·Jorge ParodiAtaúlfo Martínez-Torres
Aug 27, 2013·Neuropharmacology·Sandra I MotaA Cristina Rego
May 29, 2012·Brain : a Journal of Neurology·Aksana AndreyevaKurt Gottmann
Jun 18, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David A ScottSubhojit Roy
Mar 25, 2011·Future Medicinal Chemistry·Agenor LimonRicardo Miledi
May 2, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Joshua H K Tam, Stephen H Pasternak
Mar 5, 2016·Frontiers in Aging Neuroscience·Yanfang LiHui Zheng
Apr 16, 2016·Molecular Neurobiology·Romina María UrangaGabriela Alejandra Salvador
Jul 1, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·F Sáez-OrellanaJ Fuentealba
Mar 26, 2015·Frontiers in Neuroscience·Scarlet GallegosLuis G Aguayo
Jun 4, 2015·PloS One·Jenny DworzakPhilip M Murphy
Jan 8, 2013·Archives of Medical Research·David OrmeñoJorge Parodi
Sep 24, 2016·Journal of Alzheimer's Disease : JAD·Lan GuoHeng Du
Sep 17, 2011·American Journal of Alzheimer's Disease and Other Dementias·Nicolas FayedKeyla Aguilar
Jan 7, 2016·Physiological Reports·Shutaro KatsurabayashiKatsunori Iwasaki
Feb 16, 2018·Reviews in the Neurosciences·Allison B ReissLora J Kasselman
May 11, 2016·Journal of Alzheimer's Disease : JAD·Christian PetersLuis G Aguayo
Nov 9, 2010·Journal of Cellular and Molecular Medicine·Louise HedskogMaria Ankarcrona
May 15, 2013·Journal of Neurochemistry·Andrea C Paula-LimaSergio T Ferreira
Jun 26, 2014·Chembiochem : a European Journal of Chemical Biology·Marie C HeffernThomas J Meade
Feb 19, 2016·Journal of Alzheimer's Disease : JAD·Christian PetersLuis G Aguayo
Nov 1, 2018·Current Medicinal Chemistry·Xinwang YangEng-Ang Ling
Oct 9, 2019·Journal of Alzheimer's Disease : JAD·Ahmed Morsy, Paul C Trippier

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.